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ABSTRACT
Background. Vitamin C is an essential element required for normal metabolic
function. We investigated the effect of vitamin C supplementation on circulating
miRNA (miR) expression in subjects with poorly controlled type 2 diabetes mellitus
(T2DM). Changes in miR expression were also correlated with clinical measures of
disease.
Methods. Pre- and post-vitamin C supplementation samples from five participants
who had increased vitamin C levels, improved oxidative status and polymorphonuclear
(PMN) function after receiving 1,000 mg of vitamin C daily for six weeks were screened
for miRNA expression using the NanoString miRNA assay. Differences in miRNA
expression identified from the miRNA screen were validated by qRT-PCR.
Results. Four miRNAs showed significantly different expression post-vitamin C sup-
plementation relative to baseline, including the down-regulation of miR-451a (−1.72
fold change (FC), p= 0.036) and up-regulation of miR-1253 (0.62 FC, p= 0.027),
miR-1290 (0.53 FC, p= 0.036) and miR-644a (0.5 FC, p= 0.042). The validation study
showed onlymiR-451a expressionwas significantly different frombaselinewith vitamin
C supplementation. MiR-451a expression was negatively correlated with vitamin C
levels (r =−0.497, p= 0.049) but positively correlated with levels of malondialdehyde
(MDA) (r = 0.584,p = 0.017), cholesterol (r = 0.564,p = 0.022) and low-density
lipoproteins (LDL) (r = 0.522,p= 0.037). Bioinformatics analysis of the putative target
genes of miR-451a indicated gene functions related to signaling pathways involved
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in cellular processes, such as the mammalian target of rapamycin (mTOR) signaling
pathway.
Conclusions. Vitamin C supplementation altered circulating miR-451a expression.
The results from this pilot study suggest that miRNAs could be used as biomarkers to
indicate oxidative status in subjects with T2DM and with poor glycemic control and
could lead to a novel molecular strategy to reduce oxidative stress in T2DM.
Subjects Molecular Biology, Diabetes and Endocrinology, Nutrition, Medical Genetics
Keywords Vitamin C, miRNA, Type 2 diabetes, Oxidative stress, miRNA array
INTRODUCTION
Vitamin C, ascorbic acid or ascorbate, is well known as an antioxidant required for normal
metabolic function of the body and is associatedwith awide spectrumof biological processes
(Mandl, Szarka & Banhegyi, 2009). As an indication of the protective properties of vitamin
C, studies have shown that vitamin C can diminish the detrimental effects of hyperglycemia
such as oxidative stress, inflammation as well as endothelial dysfunction (Ceriello et al.,
2013). Several studies have also reported a beneficial effect of vitamin C supplementation
in type 2 diabetes mellitus (T2DM); a chronic metabolic disease associated with chronic
hyperglycemia and excess free fatty acids (FFAs) (Hawkins et al., 2003). This complex
disorder is characterized by insulin resistance in which the pancreas produces insufficient
insulin or there is an ineffective response (American Diabetes, 2018). The pathophysiology
of T2DM is not fully understood but high oxidative stress and low-grade inflammation are
thought to be involved and can exacerbate the development and progression of the disease.
Overproduction of reactive oxygen species (ROS) during the course of T2DM can cause
DNA and protein damage, lipid peroxidation, cellular and vascular dysfunction leading
to diabetic complications that have been associated with high levels of oxidative stress,
as indicated by the markers malondialdehyde (MDA) and F2-Isoprostanes (F2IsoPs), and
low levels of vitamin C (Bhatia et al., 2003; Johansen et al., 2005; Kaviarasan et al., 2009).
Moreover, impaired immune responses, such as neutrophil function, have been reported
in subjects with T2DM (Chanchamroen et al., 2009).
There is evidence that daily supplementationwith 1000mg/day of vitaminC for six weeks
can improve blood glucose, lipid profiles, glycated haemoglobin (HbA1C) and insulin in
subjects with T2DM (Afkhami-Ardekani & Shojaoddiny-Ardekani, 2007). The effect of
vitamin C on subjects can be observed at the gene expression level and mechanistically
may involve epigenetic regulation including via microRNAs (miRNAs or miRs) (Kolhe
et al., 2018). Supporting this model, Kim et al. (2015) revealed dietary consumption of
high dose vitamin C enhances anti-oxidation and anti-glycation as well as reduction of
inflammation-related miRNAs in lipoproteins. Furthermore, treatment of human bone
marrow stem cells with vitamin C has been shown to modulate miRNA expression in these
cells (Kolhe et al., 2018). These studies strongly suggest that vitamin C can affect miRNA
expression and may be involved in the pathophysiology of T2DM.
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MiRNAs are functional non-coding small RNAs typically 18–22nucleotides (nt) in length
that have been identified as important regulators of gene expression. These RNAmolecules
mainly act by repressing mRNA translation at the 3′ untranslated region (3′UTR) of the
target mRNA and can function in cell–cell communication (Bartel, 2004; Turchinovich,
Tonevitsky & Burwinkel, 2016). One of the important properties of these small RNAs is that
they are highly stable in various sample types such as serum or plasma and, accordingly,
can be used as a biomarker or as a target for therapeutics for several diseases including
T2DM, in which miRNA deregulation has been associated with progression of the disease
(He et al., 2017; Jimenez-Lucena et al., 2018; Maqbool & Ul Hussain, 2014; Regazzi, 2018).
However, less is known about the effect of vitamin C supplementation on miRNAs in
subjects with T2DM, especially for those subjects with poor glycemic control. In such
cases, the high oxidative stress and low levels of plasma vitamin C found in these subjects
may be influenced by miRNAs and vice versa.
To determine the effect of vitamin C supplementation on miRNA expression in
subjects with T2DM, we investigated circulating miRNAs before and after vitamin C
supplementation using a miRNA screen. We restricted the analysis to those subjects that
showed changes in plasma vitaminC levels, oxidative stress and polymorphonuclear (PMN)
function following vitamin C supplementation. We hypothesized that the expression level
of miRNAs may be affected by vitamin C supplementation and these changes may correlate
with clinical measures known to reflect the pathophysiological processes in T2DM. Such
associations may provide greater insights into the molecular mechanisms involved in these
biological processes and may be used as biomarkers for responses to the dietary treatment
of the disease leading to novel strategies in molecular targeting of relevant genes in T2DM.
MATERIALS & METHODS
Study design and participants
Archived plasma samples from a subset of participants who had received vitamin C as part
of a study examining vitamin C supplementation in subjects with T2DM (Chuangchot et
al., 2020) were utilized in this study and their usage was approved by the Human Research
Ethics Committee of Khon Kaen University in accordance with the 1964 Declaration of
Helsinki (HE571264). De-identified diagnostic measures of T2DM and clinical data of
the subjects were received from Srinagarind Hospital, Faculty of Medicine, Khon Kaen,
Thailand. The selection criteria for subjects in the larger study included age between 30 and
60 years old, diagnosed as having T2DM according to type 2 diabetes diagnostic criteria by
the American Diabetes Association (ADA) for at least 12 months, poor glycemic control
(defined by HbA1c ≥8.5% or 69.4 mmol/mol) without diabetic complications, treated
with oral diabetic drugs only (Metformin and/or Glibenclamide), sedentary and lack of
any regular exercise program for at least 6 months, and living in the Khon Kaen Province,
Thailand. Some subjects were treated with lipid-lowering drugs and/or anti-hypertensive
drugs for the duration of the study to maintain blood pressure at ≤ 140/90 mmHg.
Subjects with any other diagnosed chronic disease including neuromuscular disorder,
liver and kidney disease, positive chronic infection including human immunodeficiency
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virus, hepatitis and tuberculosis, abnormal resting electrocardiogram, changes in medical
treatment during the study period, insulin injection, blood pressure higher than 140/90mm
Hg, and smokers were excluded from the study.
The participants received 1,000 mg/day vitamin C for six weeks. Overnight fasting
blood samples were collected at pre-and post-vitamin C supplementation. Biochemical
measurements were determined as follows: HbA1c by Cobas c501 (Roche Diagnostics,
Mannheim, Germany); lipid profile by Reflotron Plus (Boehringer Mannheim, Mannheim,
Germany); fasting blood sugar by a glucose analyzer (YSI 2300 STAT PLUS, Champaign, IL
61822, USA); and insulin by an immunoradiometric assay kit ((MP Biomedical Germany
GmbH, Eschwege, Germany). Plasma vitamin C levels were measured as previously
described (Zhang et al., 2009). PMN phagocytosis and oxidative burst were determined
using flow cytometry as previously reported (Chuangchot et al., 2020). Plasma MDA
concentration was examined using the thiobarbituric acid reactive substances (TBARS)
assay (Draper et al., 1993). F2IsoPs concentration was determined using the direct 8-iso-
Prostaglandin F2α Enzyme Immunoassay kit (EIA, 8-iso-PGF2α kit, Cayman Chemical
Co). Blood samples from subjects with the following characteristics were used in this study:
increased plasma vitamin C levels; increased phagocytosis and oxidative burst; and reduced
oxidative stress as indicated by MDA and F2IsoPs concentrations at the post-vitamin C
supplementation timepoint compared to pre-supplementation. Five participants were
selected for the screening cohort and then an additional three participants were used for
the validation cohort study (n= 8).
miRNA extraction
Total RNA was extracted from archived plasma using the miRNeasy Serum/Plasma kit
(Qiagen, Germany) according to the manufacturer’s instruction. In brief, 200 uL of
the plasma was mixed with five volumes of Qiazol and a fold of chloroform. Spike-in
controls, cel-miR-39 and cel-miR-254, were added for normalization and as an indicator
of extraction efficiency. After absorption, 14 uL of RNase-free water was added to the spin
column to elute total RNA. MiRNA concentration was measured by a Nanophotometer
(IMPLEN NanoPhotometer N60, Munich, Germany).
miRNA analysis
To examine changes in miRNA expression in response to vitamin C supplementation, a
miRNA microarray screen was performed on the plasma samples from the five subjects
using the NanoString platform (NanoString Technologies, Seattle, WA, USA). The miRNA
screen includes 800 humanmature-miRNAs and expression levels can be evaluated without
an amplification step, thereby reducing the risk of PCR bias. Briefly, 3 uL of total RNA was
ligated to specific miR-tags and hybridized to a color-coded probe. Counting of miRNA
species and digital analysis of the resulting counts were performed using the nCounter
human v3 miRNA expression platform. A conservative background threshold of 100
counts was set to remove targets with low expression levels from further analysis. Six
positive controls and cel-miR-254 were used for data normalization.
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qRT-PCR
Quantitative real-time polymerase chain reaction (qRT-PCR) was performed to validate
miRNA expression levels for a select set of miRNAs in eight subjects with T2DM. The small
RNAs were converted to cDNA using the miScript II RT kit (Qiagen, Germany) following
the manufacturer’s protocol. The miScript primer assay and the miScript SYBR green PCR
kit from Qiagen were used to measure the specific miRNAs on a Bio-Rad CF96TM real time
PCR machine (Bio-Rad, Hercules, CA, USA) according to the manufacturer’s protocols.
The cel-miR-39 spike-in control was used as a reference gene. Ct values >35 were deemed
to be below background levels. Relative expression of individual miRNAs was calculated
by the 2−1Ct method.
Target gene prediction and pathway analysis
To identify the target genes of miR-451a, two bioinformatics tools Tarbase v. 8.0 and
miRTarBase v. 8.0 were used and both tools have been developed based on experimental
studies. The biological functions and enrichment pathways of these target genes were
analyzed using the Database for Annotation, Visualization and Integration Discovery
(DAVID) v. 6.8. A false discovery rate (FDR) with an adjusted P-value < 0.05 was set as
the significance threshold.
Statistical analysis
Normal distribution was tested using the Shapiro–Wilk test. Log2 transformed data by
nSolver Analysis Software v. 4.0 (NanoString Technologies) was used to analyze the
expression of each miRNA with the visual genomics analysis studio (VGAS) program
(http://www.iiid.com.au/software/vgas). Comparison of the pre- and post-vitamin C
supplementation data was performed using a paired t -test. Laboratory measures and values
from the validation study were compared between pre-and post-supplementation by paired
t -test and Wilcoxon signed ranks test using SPSS statistics v. 19 (SPSS Inc., Chicago, IL,
USA). A power of test (1-β) was checked by post-hoc analysis using G*Power v. 3.1.9.2
(Heinrich-Heine-Universität Düsseldorf, Germany). Spearman correlation was used to
analyze the correlation between circulating miRNA expression and blood parameters
and the figures were generated using GraphPad Prism v. 5.0 (GraphPad Software Inc.,
CA, USA). A p-value of <0.05 was set as the significance threshold. All data expressed as
mean ± SD.
RESULTS
Characteristics of subjects at pre- and post-vitamin C
supplementation timepoints
Subjects with T2DM in the current study had an average age of 59 years, BMI of 26 kg/m2,
HbA1c of 95 mmol/mol or 10.8% and duration of disease of 9 years (Table 1). Compared
to baseline pre-vitamin C supplementation levels, subjects showed significantly increased
plasma vitamin C levels, raised PMN phagocytosis and oxidative burst, reduced products
of lipid peroxidase (MDA and F2IsoPs), as well as reduced levels of cholesterol following
daily vitamin C supplementation for six weeks (Table 1).
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Gender (female/male) 7/1 7/1 –
Age (year) 58.8± 5.9 58.8± 5.9 –
Duration of the disease (year) 9.3± 6.6 9.3± 6.6 –
BMI (Kg/m2) 26.2± 4.1 26.2± 3.9 0.861
HbA1c (mmol/mol) 95.0± 15.0 95.0± 14.8 0.909
FBS (mmol/L) 13.0± 4.3 10.0± 2.0 0.059
Plasma ascorbate (µmol/L) 57.8± 11.0 90.5± 55.5 0.017
Plasma MDA levels (µmol/mL) 17.0± 8.6 10.6± 3.8 0.031
Plasma F2IsoPs (pg/mL) 16.9± 4.8 12.0± 4.3 0.012
Phagocytosis (%) 20.4± 8.6 30.7± 11.4 0.012
Oxidative burst (%) 5.9± 3.5 11.1± 4.5 0.006
Cholesterol (mg/dL) 239.3± 60.1 187.9± 45.9 0.050
Triglyceride (mg/dL) 168.8± 63.8 195.9± 100.1 0.217
HDL (mg/dL) 44.9± 10.6 45.9± 15.0 0.735
LDL (mg/dL) 164.9± 53.7 126.5± 32.3 0.154
Insulin (IU/mL) 14.1± 4.6 11.5± 3.6 0.057
Notes.
Data represented as mean± SD. P-value was calculated using paired t -test.
Abbreviations: BMI, body mass index; F2IsoPs, F2-Isoprostanes; FBS, fasting blood sugar; HbA1c, glycated haemoglobin;
HDL, high-density lipoproteins; LDL, low- density lipoproteins; MDA, malondialdehyde.
MiRNA screen revealed differences in the expression level of a
subset of miRNAs at pre- and post-vitamin C supplementation
A screen of circulating miRNAs in the plasma of five subjects with T2DM at pre-
and post-supplementation was performed using the NanoString platform. Of the 800
target miRNA in the screen, 26 miRNAs were expressed in all samples (Fig. S1 and
Table S1). Compared to pre-supplementation levels, four miRNAs showed significantly
different expression at post-supplementation. Of these, miR-451a was down-regulated
post-supplementation (−1.72 fold change (FC), p= 0.036), while miR-1253 (0.62 FC,
p= 0.027), miR-1290 (0.53 FC, p= 0.036) and miR-644a (0.5 FC, p= 0.042) were
up-regulated post-supplementation (Fig. 1A). MiR-451a showed the highest reduced fold
change of any of the other miRNAs tested. To validate these differences, samples from
three additional subjects with T2DM were included in the qPCR analysis. Only miR-451a
expression was found to be significantly different post-supplementation compared to the
pre-supplementation timepoint (p= 0.030) (Fig. 1B). Using the same approach as above,
we have recently demonstrated that there is no difference in the level of miR-451a in the
plasma of placebo controls pre- and post-vitamin C supplementation (Chuangchot et al.,
2020) (Fig. S2).
Correlation between expression of circulating miRNA and clinical
laboratory measures of T2DM
The expression of miR-451a was then correlated with clinical laboratory measures for
the subjects with T2DM and included all data from both the pre-and post-vitamin C
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Figure 1 Patterns of miRNA expression. (A) Analysis of circulating miRNA expression combined
with clinical measures and qRT-PCR data in response to vitamin C supplementation in T2DM subjects
with poor glycemic control (n = 5). For the miRNA, black and red bubbles represent pre-and post-
supplementation, respectively. The size of the bubbles reflects the count of the specific miRNA relative to
other miRNAs. The laboratory measures and miR-451a qRT-PCR data are indicated as a heat map from
minimum value to maximum value of each parameter independently of other parameters; yellow to blue
represents the low to high range. Pre; pre-vitamin C, Post; post-vitamin C supplementation. Numbers
represent subjects 1–5. (B) Plot represents relative expression of miR-451a as validated by qRT-PCR
(n= 8).
Full-size DOI: 10.7717/peerj.10776/fig-1
supplementation timepoints. Expression of miR-451a was negatively correlated with
plasma vitamin C levels (r =−0.497, p= 0.049, Fig. 2A) but positively correlated with
MDA (r = 0.584, p= 0.017, Fig. 2B), cholesterol (r = 0.564, p= 0.022, Fig. 2C) and LDL
(r = 0.522, p= 0.037, Fig. 2D) levels, suggesting that this miRNA might play a role in
oxidative status and lipid metabolism.
Target gene prediction and pathway enrichment analysis
Bioinformatics analysis tools were used to identify putative target genes and pathways
likely to be affected by miR-451a. A total of 88 target genes of miR-451a were retrieved
from the analysis and used in the program DAVID to identify relevant KEGG pathways.
The top enriched KEGG pathways are presented in Table 2. The target genes are involved
in several signaling pathways including mTOR signaling pathway, PI3K-Akt signaling
pathway, estrogen signaling pathway, hepatitis B, pathway in cancer and colorectal cancer,
AMPK signaling pathway, FoxO signaling pathway as well as other signaling pathways that
share target genes such as IKBKB, PIK3CA and AKT1 as shown in Table 2 (description of
genes in Table S2).
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Figure 2 Correlation betweenmiR-451a expression and laboratory variables. (A) Vitamin C levels, (B)




Type 2 diabetes mellitus (T2DM) is a worldwide health problem and continues to
increase in prevalence (Cho et al., 2018). Overproduction of ROS caused by high glucose
levels and dyslipidemia in long-standing T2DM leads to increased oxidative stress and
chronic inflammation. These features can result in diabetic complications and increased
susceptibility to infections resulting in increased morbidity and mortality, especially in
uncontrolled diabetes (Critchley et al., 2018). These pathophysiological processes could
impact miRNA expression and as suggested by numerous studies, which have investigated
several dysregulatedmiRNAs in T2DM, thesemolecules can be used as potential biomarkers
for predictive, diagnostic and therapeutic procedures (He et al., 2017; Jimenez-Lucena et
al., 2018). Furthermore, there is evidence that upregulation of miR-21 is associated with
elevated ROS levels and reduced antioxidant responses in prediabetics and subjects
with T2DM (La Sala et al., 2019), indicating miRNA may be linked with pathological
processes of the disease. Interestingly, vitamin C supplementation in subjects with T2DM
has shown positive effects on blood glucose and oxidative stress (Afkhami-Ardekani &
Shojaoddiny-Ardekani, 2007;Mazloom et al., 2011).
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Table 2 KEGG signaling pathways of miR-451a.
Term Gene targets P-value FDR
mTOR signaling pathway IKBKB, STK11, PRKAA1, CAB39, PIK3CA, AKT1, BRAF,
PIK3R1
1.35E−08 1.13E−06
PI3K-Akt signaling pathway IKBKB, ATF2, STK11, PRKAA1, PIK3CA, MYC, BCL2,
LPAR1, AKT1, PIK3R1, IL6R
5.77E−08 1.62E−04
Estrogen signaling pathway ATF2, PIK3CA, GNAQ, MMP2, AKT1, PIK3R1, MMP9 7.81E−07 1.62E−04
Hepatitis B IKBKB, ATF2, PIK3CA, MYC, BCL2, AKT1, PIK3R1,
MMP9
9.40E−07 1.62E−04
Pathways in cancer IKBKB, PIK3CA, GNAQ, MMP2, MYC, BCL2, LPAR1,
AKT1, BRAF, PIK3R1, MMP9
1.98E−05 2.39E−04
Colorectal cancer PIK3CA, MYC, BCL2, AKT1, BRAF, PIK3R1 1.99E−05 2.39E−04
AMPK signaling pathway STK11, PRKAA1, CAB39, RAB14, PIK3CA, AKT1, PIK3R1 2.99E−05 3.14E−04
FoxO signaling pathway IKBKB, STK11, PRKAA1, PIK3CA, AKT1, BRAF, PIK3R1 4.70E−05 3.95E−04
Signaling pathways regulating pluripotency of stem cells PIK3CA, PCGF5, MYC, AKT1, PIK3R1, BMI1 6.58E−05 5.02E−04
Non-alcoholic fatty liver disease (NAFLD) IKBKB, PRKAA1, PIK3CA, UQCRQ, AKT1, PIK3R1, IL6R 1.39E−04 7.81E−04
TNF signaling pathway IKBKB, ATF2, PIK3CA, AKT1, PIK3R1, MMP9 2.04E−04 1.07E−03
Insulin resistance IKBKB, PRKAA1, PIK3CA, GFPT1, AKT1, PIK3R1 2.32E−04 1.15E−03
Notes.
FDR, false discovery rate.
We hypothesized that vitamin C supplementation could modulate miRNA expression
and correlate with the blood parameters of subjects for whichwe observed improved plasma
vitamin C levels, reduced oxidative stress and increased PMN function after receiving 1,000
mg of vitamin C daily for six weeks. To our knowledge, the present study is the first report
to investigate the effect of vitamin C supplementation on miRNA expression in subjects
with T2DM and with poor glycemic control. The results from the initial miRNA screen
revealed that miR-451a was downregulated, with the highest negative fold change, after
supplementation and this was validated using qRT-PCR. However, the three significantly
upregulated miRNAs from the microarray screen did not show differences in expression
pre- and post-supplementation in the qRT-PCR validation step that also utilized additional
samples. The discrepancy between the two platforms likely reflects the low template of
these miRNAs and as such we focused only on miR-451a for further analysis.
MiR-451a (or miR-451, miRBase 22) is dicer independent and can be transcribed into
a hairpin structure and then processed with the Argonaute 2 (Ago 2) protein (Wang, Wu
& Yu, 2019). This miRNA is stable in peripheral blood and can be found in erythrocytes,
PMN,mononuclear cells and platelets (Ghai et al., 2019;Masaki et al., 2007). MiR-451a has
been reported in the blood circulation of elderly subjects with T2DM and is up-regulated
in plasma samples of subjects with diabetic nephropathy as well as in the serum of subjects
with acute diabetic Charcot foot, indicating the expressed miRNA may play a role in
pathological processes of the disease (Catanzaro et al., 2018; Pasquier et al., 2018; Sayilar et
al., 2016). In this study, the expression of miR-451a was negatively correlated with vitamin
C levels but positively correlated with MDA levels, a marker of oxidative stress, suggesting
a possible role in the oxidative status of the subjects.
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MiR-451a is also important in the erythroid lineage and plays a role in ROS production
in erythrocytes by targeting 14-3-3 zeta via the inhibition of FoxO3 (Yu et al., 2010). High
oxidative stress may affect miR-451a production as a study from Ranjan et al. found
that deficient miR-451a expression was associated with defective ROS generation due to
reduced Ago2 protein levels in macrophages (Ranjan et al., 2015). Inhibition of miR-451a
also reduced ROS, lipid peroxidation and DNA damage (Zhu et al., 2018). These data
suggest that miR-451a expression may positively correlate with ROS production. In this
study, miR-451a expression showed a positive correlation with cholesterol and LDL.
These factors may exacerbate the progression of the disease accompanied with miR-451a
expression. However, further work is needed to confirm the correlation of miR-451a with
oxidative stress as found in the current study.
We also investigated the target genes of miR-451a and their functional enrichment
using experimentally validated datasets. The target genes were significantly involved in
signaling pathways that play an important role in cellular functions of biological processes
as shown in Fig. 3 and Table 2. To support our results, studies in T2DM cardiomyopathy-
induced mice with high ROS production displayed up-regulation of miR-451a that directly
targeted calcium-binding protein 39 (CAB39) and resulted in down-regulation of the
LKB1/AMPK signaling pathway. These target genes are listed in Table 2. Furthermore,
knockout of this miRNA showed the opposite effect (Kuwabara et al., 2015). Thus, the
data suggests that miR-451a expression was induced by high oxidative stress leading to
suppression of the AMPK pathway, a central energy-sensing of metabolic regulation, which
was found to have reduced activity in insulin-resistant individuals (Li et al., 2019; Xu et
al., 2012). The reduced ROS production found in the subjects with T2DM in this study
after vitamin C supplementation and with down-regulation of miR-451a may be through
CAB39/LKB1/AMPK signaling, as PI3K/AKT/mTOR signaling is the central pathway of
glucose and lipid metabolism (Huang et al., 2018; Tuo & Xiang, 2018). Hyperglycemia
and excess FFAs lead to insulin resistance and high levels of ROS resulting in impaired
PI3K/AKT/mTOR signaling found in subjects with T2DM (Huang et al., 2018). Moreover,
reduction of oxidative stress has been reported in subjects with up-regulation of AKT
and mTOR after pretreatment with vitamin C (Lin et al., 2016). MiR-451a could target
multiple genes involved in the PI3K/AKT/mTOR signaling pathway including AKT1,
PIK3CA, PIK3R1, and PRKAA1 (as indicated in Table 2 and Table S2). In addition, IKBKB
is one of the target genes of miR-451a (Li et al., 2013) and is a known inhibitor of the NF-kB
complex that can be activated by multiple harmful cellular stimuli such as stress or free
radicals. There is evidence that vitamin C can also diminish NF-kB activation by directly
inhibiting IKK β, aside from quenching ROS (Carcamo et al., 2004). The miRNA may be
involved in this synergistic effect of vitamin C in response to ROS. Supplementation with
vitamin C in the subjects might help to promote these pathways through the regulation of
miR-451a. Further studies are required to explore the mechanisms behind the effects of
vitamin C supplementation on this circulating miRNA associated with systemic oxidative
stress in the subjects.
The participants in this study showed enhanced phagocytosis and oxidative burst
after supplementation of vitamin C, which is consistent with previous studies that have
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Figure 3 Proposed mechanism of the effect of miR-451a in response to vitamin C supplementation.
Red lines represent the results of this study and blue lines indicate potential mode of interaction for miR-
451a. Poor glycemic controlled T2DM subjects receiving vitamin C 1,000 mg daily for six weeks showed
significant down-regulation of circulating miR-451a accompanied with increased levels of vitamin C,
reduced oxidative stress (MDA and F2IsoPs) and increased PMN function (phagocytosis and oxidative
burst). Changes in oxidative status may modulate miR-451a expression by altering Ago2 protein and/or
increased involvement of signaling pathways such as AMPK signaling by repressing its target genes. MiR-
451a may play a role in neutrophil chemotaxis by targeting RAB5A and 14-3-3zeta resulting in the acti-
vation of p38 MAPK signaling. However, the role of this miRNA in phagocytosis and oxidative burst of
neutrophils is still to be explored (dotted line) and may be reflected in intracellular miRNA changes rather
than circulating changes as identified in this study.
Full-size DOI: 10.7717/peerj.10776/fig-3
shown the effect of vitamin C in enhancing PMN function such as motility, chemotaxis,
phagocytosis and microbial killing (Bozonet et al., 2015; Carr & Maggini, 2017). However,
knowledge of the molecular mechanisms of the effect of vitamin C on these processes,
especially phagocytosis and oxidative burst, are limited. MiR-451a has been reported to
impact neutrophil chemotaxis by suppressing p38 MAPK through targeting Rab5a and
14-3-3 zeta (Murata et al., 2014). Rab5a, a small GTPase, regulates intracellular membrane
trafficking involved in phagolysosome fusion during bacteria phagocytosis of neutrophils
(Perskvist et al., 2002). Moreover, treatment of human bladder cancer cells by vitamin C
could suppress p38 MAPK activity and ROS production (Kim et al., 2008). As suggested
from these data, vitamin C may affect miR-451a expression and associate with neutrophil
function through targeting Rab5a and the p38 MAPK pathway. However, investigation
of intracellular miRNAs in response to vitamin C supplementation may help us to better
understand the molecular mechanism underlying PMN function that we clearly observed
in these subjects. A proposed mechanism of action for miR-451a in response to vitamin C
supplementation is shown in Fig. 3.
Limitations of this pilot study include a small sample size. Increasing the number
of the participants may better clarify the association of the candidate miRNA and the
laboratory measures including improved oxidative status and PMN functions as well as
reduced cholesterol after vitamin C supplementation. Nevertheless, the power of the test
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based on the difference between the two dependent groups using the mean and SD. of
relative miR-451a data revealed that the effect size was 1.15 and the power of the test
was approximated at 80%. Furthermore, the recent study compared only the miRNA
expression between the pre-and post-vitamin C supplementation. However, our previous
study of subjects receiving placebo showed no difference inmiR-451a expression at pre-and
post-supplementation as represented in Fig. S2. More research is needed to confirm and
validate the finding that vitamin C intake modulates circulating miR-451a expression and
to determine the functional role of this miRNA in subjects with uncontrolled T2DM.
CONCLUSIONS
In conclusion, this study has identified a novel association between vitamin C
supplementation for six weeks and reduced circulating miR-451a expression in subjects
with poorly controlled T2DM. This candidate miRNA may be used as a biomarker to
identify subjects that respond to vitamin C treatment or oxidative status in plasma.
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